Organon (OGN) announced that the FDA extended by three months the target action date of its review of the supplemental New Drug Application, or ...

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

The annual meeting of the American College of Allergy, Asthma & Immunology was held from Oct. 24 to 28 in Boston, drawing ...

New results show Eli Lilly Ebglyss (lebrikizumab-lbkz) improved skin (including hand and face) and itch among patients with ...

The partial clinical hold only applies to the Phase III PRESERVE-003 trial of gotistobart. Image credit: Andrii Yalanskyi / Shutterstock. The US Food and Drug Administration (FDA) has placed a partial ...

Back in September, Lilly received FDA approval for its atopic dermatitis medication Ebglyss. Atopic dermatitis is more commonly referred to as eczema. Eczema is generally treated with topical ...

Atopic dermatitis (eczema) is diagnosed by a healthcare provider based on a combination of a person's symptoms and medical history, as well as a physical exam. Laboratory tests are sometimes performed ...

The most common form of eczema is atopic dermatitis, and the terms are often used interchangeably. The condition often crops up during childhood, experts said. And while some people outgrow it ...

However, there are different types of eczema that affect people in different ways at different stages of their life. The most common type of eczema, atopic dermatitis is an inflammatory skin condition ...

New Delhi: Vodafone Idea (Vi), boosted by equity funding, is set to start rolling out next generation (5G) commercial services by March 2025 across 17 circles, starting with Delhi and Mumbai, and is ...